Alexander Snow

Lansdowne Partners (UK) LLP (Lansdowne) is the alternative investment management subsidiary of Lansdowne Partners Ltd., itself a subsidiary of Lansdowne Partners International Ltd. in the Cayman Islands. The firm is headquartered in London and was founded in 1998. Lansdowne provides investment advisory services on a discretionary basis to their clients, which includes commingled investment vehicles intended for institutional investors and other sophisticated investors and investment vehicles formed for particular investors and separately managed accounts for sophisticated financial institutions, including registered investment companies. Lansdowne is a signatory to the United Nations Principles of Responsible Investing (UNPRI).

The Evolution Group Plc provides investment banking and financial services. It offers corporate finance, advisory, corporate broking, debt and equity capital markets, fixed income sales and trading, equity sales and trading services. The company was founded on May 26, 1997 and is headquartered in London, the United Kingdom.

Investec Bank Plc provides investment banking services. It also offers foreign exchange services, structured products and investment funds, property finance, mortgages and lending, and investment management services. The company was founded on December 20, 1950 and is headquartered in London, the United Kingdom.

Williams de Broë Ltd. (WDB) is the wholly-owned investment management subsidiary of Investec Wealth & Investment Ltd., itself a subsidiary of Investec Plc in Great Britain. Founded in 1869, WDB is based in London, and has additional offices in Birmingham, Bournemouth, Edinburgh, Exeter, Bath and Guildford. The firm specializes in managing money for private investors, offering private portfolio management, discretionary management and financial advisory services. They also manage a range of mutual funds.

Amerisur Resources Plc engages in the exploration and production of oil and gas. It operates through the following geographical segments: UK, Colombia, and Paraguay. Its projects include Platanillo, Putumayo-9, Putumayo-12, Putumayo-8, Putumayo-30, Coati Block, CPO-5, Andaquies Block, Terecay, Tacacho, and Mecaya. The company was founded on July 5, 2000 and is headquartered in London, the United Kingdom.

Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom.